Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03444116 · ClinicalTrials.gov registry record

Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy

A clinical trial, sponsored by Gillette Children's Specialty Healthcare.

Completed
Registry status
62
Enrollment target

NCT03444116 is a clinical trial that has completed, run by Gillette Children's Specialty Healthcare. The registered enrollment target is 62 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03444116 has completed, sponsored by Gillette Children's Specialty Healthcare.

COMPLETED
Registry status
62 participants
Enrollment target

Study Summary

Excessive anteversion is commonly observed in the cerebral palsy (CP) population. This can be treated by an orthopedic surgery, called femoral derotation osteotomy (FDO), to de-rotate the femur. It is a vital aspect of patient care to understand if the effects of an FDO are maintained long-term. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families by providing families the information needed to make the most informed decision possible about this aspect of their child's healthcare.

Interventions

  • BEHAVIORAL Surveys
  • DIAGNOSTIC_TEST Motion Analysis
  • DIAGNOSTIC_TEST sterEOS Imaging of Lower Extremities

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2017-09-12
Est. Completion 2019-11-15

What the Registry Record Tells You About NCT03444116

The ClinicalTrials.gov registry entry for NCT03444116 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gillette Children's Specialty Healthcare, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Surveys is the first listed.

NCT03444116 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03444116 about?

NCT03444116 is a clinical study titled "Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy". Excessive anteversion is commonly observed in the cerebral palsy (CP) population. This can be treated by an orthopedic surgery, called femoral derotation osteotomy (FDO), to de-rotate the femur. It is a vital aspect of patient care to understand if the effects of an FDO are maintained long-term. The...

What is the current status of trial NCT03444116?

This trial is currently completed. The enrollment target is 62 participants. The study started on 2017-09-12. Estimated completion is 2019-11-15.

What interventions are being tested in trial NCT03444116?

The interventions under investigation include: Surveys (BEHAVIORAL), Motion Analysis (DIAGNOSTIC_TEST), sterEOS Imaging of Lower Extremities (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03444116?

This trial is sponsored by Gillette Children's Specialty Healthcare, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.